again with the loss of one carbon atom.8 In this context also
the bis(carbene) species [B12H10{C(OH)2}2] may also be noted.9
Complexes of elements of Main-Group III (i.e. Group 13) with
carbenes are rare,10 as is loss of carbon from isocyanides upon
reaction with boron-containing clusters.11
C13H43B18IrN2: M = 614.27, monoclinic (yellow prism, 0.52 × 0.38 ×
0.22 mm, from CH2Cl2/C6H14), space group P21/n, a = 12.6547(2),
b = 11.4546(2), c = 21.2777(4) Å, β = 104.5570(11)Њ, U = 2985.29(9)
Å3, Dcalc = 1.367 Mg mϪ3, Z = 4, Mo-Kα, λ = 0.71073 Å, µ = 4.480
mm1, T = 160(2) K, R1{I > 2σ(I )} = 0.0390 and wR2 = 0.1132 for all
27971 collcted reflections. CCDC reference numbers 233343 (3) and
crystallographic data in CIF or other electronic format. For both 3
and 4, methods and programs were standard: G. M. Sheldrick,
SHELXS-97, Program for solution of crystal structures, University
of Göttingen, Germany, 1997; G. M. Sheldrick, SHELXL-97,
Program for refinement of crystal structures, University of
Göttingen, Germany, 1997.
Acknowledgements
ˇ
Contribution no. 92 from the Rez–Leeds Anglo–Czech
ˇ
Polyhedral Collaboration (ACPC). We thank the UK EPSRC
(grants nos. F/78323, J/56929, K/05818 and M/83360, and a
studentship to SLS), the Grant Agency of the Academy of
Sciences of the Czech Republic (Grant no. A 403 2701), the
Royal Society for help with reciprocal visits, Simon Barrett
for assistance with NMR spectroscopy, and Colin Kilner for
crystallographic help.
6 Criteria of bulk purity and identity were clean NMR spectra
consistent with the results of the X-ray diffraction analysis. In each
case positive-ion mass spectrometry (EI, 70 eV) gave highest
mass isotopomer envelopes corresponding to a mixture of Mϩ and
(M Ϫ 2H)ϩ, with principal fragmentations involving loss of PMe2Ph
(compound 3) and loss of {Me} and {C(NHMe)2} (compound 4).
NMR data at 297–300 K (CDCl3), ordered as δ(11B)/ppm [δ(1H)/
ppm of directly bound hydrogen atoms] (relative intensity): for
[(η5-C5Me5)HIrB18H19(PMe2Ph)] (compound 3) — ca. ϩ17.0 [ϩ3.86]
(1BH), ϩ16.5 [ϩ3.95] (1BH), ϩ5.0 [no exo H] (1B), ϩ2.9 [ϩ3.25]
(1BH), ca. ϩ1.5 [ϩ4.79] (1BH), ca. ϩ0.7 [ϩ3.01] (1BH), ca. Ϫ1.0
[ϩ2.30] (1BH), Ϫ2.0 [ϩ2.14] (1BH), Ϫ8.7 [ϩ1.98] (1BH), ca. Ϫ10.8
[no exo H] (1B), ca. Ϫ11.7 [ϩ1.97] (1BH), ca. Ϫ16.2 [ϩ2.03] (1BH),
ca. Ϫ16.8 [ϩ2.11] (1BH), ca. Ϫ20.4 [no exo H, unresolved coupling
1J(31P–11B) ca. 150 Hz] (1B), ca. Ϫ21.7 [ϩ0.15] (1BH), Ϫ25.3 [ϩ1.74]
(1BH), Ϫ29.4 [Ϫ1.24] (1BH), Ϫ40.0 [ϩ 0.07] (1BH); additionally
δ(1H) at ϩ1.12, Ϫ1.02, Ϫ2.63 [unresolved doublet splitting
2J(31P–1H) ] and Ϫ2.89 (4 × Hµ), at ϩ2.06 (15H, C5Me5), at ϩ1.98
(3H, PMe) and ϩ1.94 (3H, PMe), and at Ϫ14.89 (1H, IrH), with
δ(31P) Ϫ2.6 ppm [unresolved coupling 1J(31P–11B) ca. 150 Hz]; for
[(η5-C5Me5)HIrB18H19{C(NHMe)2}] (compound 4) — ca. ϩ6.0
[ϩ3.81] (1BH), ca. ϩ16.7 [ϩ3.98] (1BH), ϩ5.0 [no exo H] (1B), ϩ2.0
[ϩ3.22] (1BH), ca. ϩ0.5 [ϩ4.83] (1BH), ca. ϩ0.1 [ϩ3.01] (1BH),
Ϫ2.2 [ϩ2.31] (1BH), ca. Ϫ2.0 [ϩ1.95] (1BH), Ϫ10.9 [ϩ1.58] (1BH),
Ϫ10.2 [no exo H] (1B), ca. Ϫ9.1 [ϩ1.99] (1BH), ca. Ϫ17.5 [ϩ2.00]
(1BH), ca. Ϫ17.0 [ϩ2.38] (1BH), Ϫ16.4 [no exo H] (1B), ca. Ϫ22.1
[ϩ0.13] (1BH), Ϫ25.8 [ϩ1.70] (1BH), Ϫ28.9 [Ϫ1.17] (1BH), Ϫ40.3
[ϩ 0.08] (1BH); additionally δ(1H) at ϩ1.12, Ϫ1.04, Ϫ2.57 and
Ϫ2.84 (4 × Hµ), at ϩ2.07 (15H, C5Me5), at ϩ3.20 (3H, NMe) and
ϩ2.92 (3H, NMe), at ϩ0.96 (1NH) and ϩ0.88 (1NH) and at Ϫ14.93
(1H, IrH).
References
† A IUPAC nomenclature for compound 3 would be 11-(dimethyl-
phenylphosphine)-9-pentahapto-pentamethylcyclopentadienyl-9-
hydrido-nido-9-iridaundecaborano-〈7,8:5Ј,6Ј〉-nido-decaborane.
‡ A IUPAC nomenclature for compound 4 would be 11-{bis(methyl-
amino)carbene}-9-pentahapto-pentamethylcyclopentadienyl-9-
hydrido-nido-9-iridaundecaborano-〈7,8:5Ј,6Ј〉-nido-decaborane.
1 R. E. Williams, Inorg. Chem., 1971, 10, 210; R. E. Williams,
Adv. Inorg. Chem. Radiochem., 1976, 18, 64; R. E. Williams, Adv.
Organomet. Chem., 1994, 36, 1; K. Wade, Chem. Commmun., 1971,
79; K. Wade, Adv. Inorg. Chem. Radiochem., 1976, 18, 1.
2 J. D. Kennedy, in Advances in Boron Chemistry, ed. W. Siebert, Royal
Society of Chemistry, Cambridge, 1997, pp. 451–462; T. Jelínek,
ˇ
B. Stíbr, J. D. Kennedy and M. Thornton-Pett, in Advances in Boron
Chemistry, ed. W. Siebert, Royal Society of Chemistry, Cambridge,
ˇ
1997, pp. 426–429; T. Jelínek, J. D. Kennedy, B. Stíbr and
M. Thornton-Pett, Inorg. Chem. Commun., 1998, 1, 179; T. Jelínek,
ˇ
I. Cisarˇová, B. Stíbr, J. D. Kennedy and M. Thornton-Pett, J. Chem.
Soc., Dalton Trans., 1998, 2965; J. Bould, W. Clegg, S. J. Teat,
L. Barton, N. P. Rath, M. Thornton-Pett and J. D. Kennedy, Inorg.
Chim. Acta, 1999, 289, 95.
ˇ
3 S. L. Shea, T. D. McGrath, T. Jelínek, B. Stíbr, M. Thornton-Pett
ˇ
and J. D. Kennedy, Inorg. Chem. Commun., 1998, 1, 97.
7 R. Macías, J. Holub, W. Clegg, M. Thornton-Pett, B. Stíbr and
4 P. Kaur, A. Brownless, S. D. Perera, P. A. Cooke, T. Jelínek,
J. D. Kennedy, J. Chem. Soc., Dalton Trans., 1997, 149.
ˇ
ˇ
J. D. Kennedy, M. Thornton-Pett and B. Stíbr, J. Organomet. Chem.,
8 T. Jelínek, J. D. Kennedy, B. Stíbr and M. Thornton-Pett, J. Chem.
1998, 557, 181.
Soc., Chem. Commun., 1994, 1999.
9 M. A. Fox, J. A. K. Howard, J. M. Moloney and K. Wade, Chem.
Commun., 1998, 2487.
5 Single-crystal X-ray data: compound 3, [(η5-C5Me5)HIrB18H19-
(PMe2Ph)], C18H46B18IrP: M = 680.30, triclinic (yellow block, 0.52 ×
¯
0.35 × 0.32 mm, from CH2Cl2/C6H14), space group P1, a =
10 See, for example, A. A. Arduengo, H. V. R. Dias, J. C. Calabrese and
F. Davidson, J. Am. Chem. Soc., 1992, 114, 9724.
11 E. J. Ditzel, X. L. R. Fontaine, N. N. Greenwood, J. D. Kennedy,
10.2788(9), b = 17.251(2), c = 18.126(2) Å, α = 99.201(8)Њ, β =
98.006(9)Њ, γ = 90.678(8)Њ, U = 3140.0(5) Å3, Dcalc = 1.439 Mg mϪ3
,
Z = 4, Mo-Kα, λ = 0.71073 Å, µ = 4.314 mm1, T = 160(2) K,
R1{I > 2σ(I )} = 0.0318 and wR2 = 0.0692 for all 10075 reflections
collected; compound 4, syn-[(η5-C5Me5)HIrB18H19{C(NHMe)2}],
Zhu Sisan, B. Stíbr and M. Thornton-Pett, J. Chem. Soc., Chem.
ˇ
Commun., 1990, 1741.
12 P. McArdle, ORTEX, version 5, J. Appl. Crystallogr., 1995, 28, 65.
D a l t o n T r a n s . , 2 0 0 4 , 1 5 2 1 – 1 5 2 3
1523